Data Back New Surrogate Endpoint to Accelerate AML Drug Development – Oncology News Central

Written by

admin

in

  1. Data Back New Surrogate Endpoint to Accelerate AML Drug Development  Oncology News Central
  2. Prognostic relevance of limit of quantification as low-level cutoff for flow cytometry-based measurable residual disease assessment in acute myeloid leukemia  Nature
  3. What Does Minimal Residual Disease Mean?  Cure Today
  4. MRD May Predict Survival in Induction Chemotherapy AML Trials  CancerNetwork
  5. Measurable residual disease an early marker for treatment response in AML  Healio

Continue Reading

More posts